PCR92 Treatment Preference of Moderate or Severe Hemophilia a Patients in Taiwan
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.2027
https://www.valueinhealthjournal.com/article/S1098-3015(22)04232-2/fulltext
Title :
PCR92 Treatment Preference of Moderate or Severe Hemophilia a Patients in Taiwan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04232-2&doi=10.1016/j.jval.2022.09.2027
First page :
Section Title :
Open access? :
No
Section Order :
11583